Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.All patients who are COVID-19 positive by either COVID-19 RTPCR test or COVID-19 rapid antigen test or HRCT chest suggestive of active COVID-19 infection (CORADS III AND ABOVE) 2.All genders 3.Age above 18 years 4.Patients willing to give consent for this study
Exclusion criteria
Exclusion criteria: 1.Patients who are COVID-19 negative 2.Patients who have taken Vitamin B12 supplements 3.Patients who might have raised D-Dimer due to other known causes; e.g. heart disease, prolonged bed rest, post surgical, etc 4.Pregnant and lactating women 5.Age 6.Patients not willing to give consent for this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.To measure baseline Vitamin B12 levels in COVID19 positive patients 2.To measure baseline D Dimer levels in these patients 3.To measure maximum D Dimer levels in these patients through the course of hospital stay 4.To analyse following in the study population: Duration of hospital stay Need for oxygen support Need for anticoagulation Clinical outcome(recovered/expired) Timepoint: 2 months | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare thrombotic events in persons with Vitamin B12 deficiency and in those with normal levelsTimepoint: 2 months | — |
Countries
India
Contacts
GCS Medical College, Hospital and Research Centre